Helena Lanzafame
Impact in
-
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
- Oncology 7
- Peptidase Inhibition and Analysis 6
-
- Radiopharmaceutical Chemistry and Applications 4
- Radiomics and Machine Learning in Medical Imaging 2
- Co-authors
- Kim M. Pabst (6 shared papers)Wolfgang P. Fendler (8 shared papers)Rainer Hamacher (6 shared papers)Jens T. Siveke (6 shared papers)Irene A. Burger (2 shared papers)Sergio Baldari (3 shared papers)Ken Herrmann (5 shared papers)Maria Picchio (1 shared paper)
- Journals
- Journal of Nuclear Medicine (6 papers)Journal of Clinical Oncology (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Nuclear Medicine Communications (1 paper)Cancers (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Helena Lanzafame
13 papers receiving 124 citations
Peers
Comparison fields: 5 of 26
- Oncology 53
- Radiology, Nuclear Medicine and Imaging 41
- Cancer Research 20
- Endocrinology, Diabetes and Metabolism 20
- Pulmonary and Respiratory Medicine 38
Countries citing papers authored by Helena Lanzafame
This map shows the geographic impact of Helena Lanzafame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Lanzafame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Lanzafame more than expected).
Fields of papers citing papers by Helena Lanzafame
This network shows the impact of papers produced by Helena Lanzafame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Lanzafame. The network helps show where Helena Lanzafame may publish in the future.
Co-authors
The 25 scholars most cited alongside Helena Lanzafame, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 26 | |
| 2 | 2024 | 20 | |
| 3 | 2021 | 18 | |
| 4 | 2022 | 12 | |
| 5 | 2023 | 12 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2025 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2026 | 1 |
About Helena Lanzafame
Helena Lanzafame is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 13 papers that have together received 124 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Prostate Cancer Treatment and Research (4 papers), Protease and Inhibitor Mechanisms (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Cardiac Structural Anomalies and Repair (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (53 citations), Radiology, Nuclear Medicine and Imaging (41 citations), Cancer Research (20 citations), Endocrinology, Diabetes and Metabolism (20 citations) and Pulmonary and Respiratory Medicine (38 citations). Helena Lanzafame has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Kim M. Pabst, Wolfgang P. Fendler, Rainer Hamacher, Jens T. Siveke, Irene A. Burger, Sergio Baldari, Ken Herrmann, Maria Picchio, Fabio Minutoli and Paola Mapelli. Their work appears in journals such as Journal of Nuclear Medicine, Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine Communications and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.